Evidence map›Paper›PMID 36148046›Full record

ReviewBritish journal of biomedical science2022

SARS-CoV-2 and COVID-19: A Narrative Review.

A D Blann, R Heitmar

Registry-linked trialAbstract readReview
In one paragraph

Review in British journal of biomedical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06548841 (Development and Validation of), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06548841 completednot on this mapstarted 2024, after this paper: background citation

Development and Validation of (Bio)Sensors for the Identification of Pathogens

TypeobservationalSponsorUniversity of BolognaRan2024 to 2025Enrolled149ConditionsInfections, Infection, Bacterial, Infection Viral, Infection, ParasiteArmsNanobiotechnology platforms
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Remdesivir: treatment of COVID-19 in special populations.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A D BlannSchool of Applied Sciences, University of Huddersfield Queensgate, Huddersfield, United Kingdom.
R HeitmarSchool of Applied Sciences, University of Huddersfield Queensgate, Huddersfield, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organisation has reported that the viral disease known as COVID-19, caused by SARS-CoV-2, is the leading cause of death by a single infectious agent. This narrative review examines certain components of the pandemic: its origins, early clinical data, global and UK-focussed epidemiology, vaccination, variants, and long COVID.

Indexed as

COVID-19SARS-CoV-2HumansPandemicsPost-Acute COVID-19 SyndromeCOVID-19long COVIDSARS-CoV-2vaccinationvariants

Identifiers

PMID36148046
PMCPMC9486701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.